Tackling COVID-19 with neutralizing monoclonal antibodies

Cell
Jun 10, 2021 Volume 184 Issue 12 p3075-3348
https://www.cell.com/cell/current

 

Review
Tackling COVID-19 with neutralizing monoclonal antibodies
Davide Corti, Lisa A. Purcell, Gyorgy Snell, David Veesler
Intense efforts have been made to develop or identify drugs to treat people with COVID-19. Monoclonal antibodies are one of the few types of drugs that have shown efficacy in the clinic.